Cipla Set To Launch Favipiravir Drug For Treatment Of COVID Patients

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for the treatment of COVID-19 patients,...

from NDTV News - Latest https://ift.tt/2ORjxma
https://ift.tt/eA8V8J July 24, 2020 at 06:53AM

Comments

Popular posts from this blog

Watch: Man Shows What It Looks Like To Go On A Coffee Date With Three Cats In New York